Indian pharma grows for 5th straight month; sales rise 4.5% in January
Growth in the Indian pharma market is expected to be linear ahead. The market has now grown for the fifth consecutive month and the momentum is likely to improve
Niti Kiran | February 14, 2021 | Updated 12:54 IST
The Indian pharmaceutical market's (IPM) maintained its growth trajectory for the fifth consecutive month by expanding 4.5 per cent in January. After growing 8.5 per cent in December, it grew 4.5 per cent last month, signalling that the post-Covid recovery is in full swing, pointed an Anand Rathi report.
Listed pharma companies that drove growth were Ajanta which grew 16 per cent, JB Chemicals (13.5 per cent), Ipca (12.5 per cent), Alkem (9.3 per cent) and Zydus Cadila (8.1 per cent). However, a few reported declines -- sales of Natco were down 38.4 per cent, Indoco (down 5.1 per cent), Alembic (down 3.6 per cent) and FDC (down 2.7 per cent).